WallStreetZenWallStreetZen

NASDAQ: BDRX
Biodexa Pharmaceuticals PLC Earnings & Revenue

BDRX past revenue growth

How has BDRX's revenue growth performed historically?
Company
-33.91%
Industry
154.55%
Market
17.87%
BDRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BDRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BDRX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BDRX earnings and revenue history

Current Revenue
$377.2k
Current Earnings
-$4.5M
Current Profit Margin
-1,197.3%

BDRX Return on Equity

Current Company
-45.3%
Current Industry
1.3%
Current Market
-0.3%
BDRX's Return on Equity (-55.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BDRX announces earnings.

BDRX Return on Assets

Current Company
-34.2%
Current Industry
-1.5%
BDRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BDRX Return on Capital Employed

Current Company
-67.51%
Current Industry
11.8%
BDRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BDRX$359.04k-$4.25M-$4.30M-23.29%N/A
ALLR$0.00-$11.28M-$20.42M-100.00%N/A
APVO$0.00-$16.84M-$17.41M-100.00%N/A
ADTX$749.48k-$26.55M-$29.73M-12.15%N/A
VRAX$79.30kN/A-$6.92M-15.02%N/A

Biodexa Pharmaceuticals Earnings & Revenue FAQ

What were BDRX's earnings last quarter?

Biodexa Pharmaceuticals (NASDAQ: BDRX) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Biodexa Pharmaceuticals earnings for the quarter were N/A. In the same quarter last year, Biodexa Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Biodexa Pharmaceuticals stock.

What was BDRX's earnings growth in the past year?

As of Q2 2024, Biodexa Pharmaceuticals's earnings has grown year over year. Biodexa Pharmaceuticals's earnings in the past year totalled -$4.30 million.

What was BDRX's revenue last quarter?

Biodexa Pharmaceuticals (NASDAQ: BDRX) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Biodexa Pharmaceuticals's revenue was N/A.

What was BDRX's revenue growth in the past year?

As of Q2 2024, Biodexa Pharmaceuticals's revenue has grown -33.91% year over year. This is 188.46 percentage points lower than the US Biotechnology industry revenue growth rate of 154.55%. Biodexa Pharmaceuticals's revenue in the past year totalled $359.04 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.